# Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems

> **NCT00715884** · NA · UNKNOWN · sponsor: **Cordis US Corp.** · enrollment: 678 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Atherosclerosis

## Interventions

- **DEVICE:** CYPHER® ELITE™ Sirolimus-Eluting Stent System
- **DEVICE:** CYPHER® Bx VELOCITY® Sirolimus-eluting Stent System

## Key facts

- **NCT ID:** NCT00715884
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2010-03
- **Final completion:** 2014-09
- **Target enrollment:** 678 (ACTUAL)
- **Last updated:** 2014-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00715884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00715884, "Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00715884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*